A report has been compiled on the behaviour of American cycling legend Lance Armstrong during a recent out of competition drug test, the French Anti-doping Agency (AFLD) announced on Monday.
AFLD president Pierre Bordry revealed that he had sent the report to the International Cycling Union (UCI) and the World Anti-Doping Agency (WADA) on March 30. He did not reveal the report’s contents.
The AFLD sent a sample-taker to test Armstrong after a training session at Saint-Jean-Cap-Ferrat on the Cote d’Azur on March 17. The official took a sample of urine, blood and other bodily matter.
According to the AFLD, the sample-taker warned Armstrong that he would compile a report about his attitude.
“The UCI does not have jurisdiction to judge this case,” said UCI press officer Enrico Carpani, referring to articles nine and 13 of the organisation’s anti-doping legislation.
“As it concerns a test carried out by a national agency that happened outside of competition, it’s the agency which has the authority.”
The AFLD will await a response from the UCI before deciding whether or not Armstrong’s behaviour constitutes an infringement of the world anti-doping code.